Uphill Pharmaceuticals Private Limited
About Uphill Pharmaceuticals Private Limited
Data last updated:
Uphill Pharmaceuticals Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 26 December 2006.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2006PTC157020.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Its last annual general meeting (AGM) was held on 27 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at House No. 21 1st Floor Blk – D Parshant Vihar Landmark Near Central Market, New Delhi, Delhi, India – 110085.
As per the financials filed for FY 2020, the company reported a revenue of ₹68,400, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹11,899 (net margin 17.4%) and EBITDA of ₹14,099 (EBITDA margin 20.6%).
Company details
Contact details
Uphill Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 21 1st Floor Blk – D Parshant Vihar Landmark Near Central Market, New Delhi, Delhi, India – 110085
- IndustryBusiness Outsourcing, Business & IT Consulting
To see the full contact details of Uphill Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Uphill Pharmaceuticals is professional, scientific and technical. In detail, this covers management consultancy activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M3 | Management consultancy activities |
To see the full business activity and turnover split of Uphill Pharmaceuticals Private Limited, buy the company report.
Financials of Uphill Pharmaceuticals Private Limited
FY 2020 filings availableUphill Pharmaceuticals Private Limited reported revenue of ₹68,400 (down 2% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year. EBITDA rose 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹68,400 | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14,099 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11,899 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.6% | ||||
| Net Profit Margin | 17.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Uphill Pharmaceuticals Private Limited, buy the company report.
Board of directors of Uphill Pharmaceuticals Private Limited
Uphill Pharmaceuticals has 8 former directors on record and no current directors listed.
Auditor
Uphill Pharmaceuticals Private Limited is audited by SANTOSH GUPTA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANTOSH GUPTA & CO | FY 2020 | 009713N |
Shareholding
The shareholding of Uphill Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Uphill Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Uphill Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Uphill Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Uphill Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Uphill Pharmaceuticals Private Limited has 8 board changes on record since 2012: 0 appointments and 8 cessations. The latest: Manish Kumar ceased to be Director on 03 May 2021.
Frequently asked questions
Uphill Pharmaceuticals has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Uphill Pharmaceuticals was a private limited company based in New Delhi, Delhi, India. The company worked in business and IT consulting, within the business outsourcing industry. It was incorporated on 26 December 2006 and is registered under CIN U24232DL2006PTC157020. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Uphill Pharmaceuticals is U24232DL2006PTC157020. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Uphill Pharmaceuticals was incorporated on 26 December 2006. It is registered with the Registrar of Companies, Delhi.
The registered office of Uphill Pharmaceuticals is at House No. 21 1st Floor Blk – D Parshant Vihar Landmark Near Central Market, New Delhi, Delhi, India – 110085.
The latest financial statements of Uphill Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 27 December 2020. Year-wise statements from 2015 are in the company report.
Uphill Pharmaceuticals operated in the business outsourcing industry, in the business and IT consulting segment.
Manish Kumar ceased to be Director on 03 May 2021. Meenakshi Peshawari ceased to be Additional Director on 03 May 2021. Purva Peshawari ceased to be Director on 03 May 2021. Uphill Pharmaceuticals has 8 board changes on record in total.
The compliance status of Uphill Pharmaceuticals is compliant as of 20 August 2026.
Uphill Pharmaceuticals can be reached at its registered office: House No. 21 1st Floor Blk – D Parshant Vihar Landmark Near Central Market, New Delhi, Delhi, India – 110085.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
